TGFB1 and cervical cancer: Our findings indicate that TGF-β1 or EGF-β induces EMT but dose not alter miR-375 expression in cervical cancer cells, and mesenchymal cell-like cervical cancer cells induced by TGF-β1 or EGF-β are typically paclitaxel resistant.